ELMS STEVE

Director Steve Elms buys 14,000 shares (2 transactions, $217.4K) at $15.67 and $15.39, near 52-week low amid -20.2% 90-day decline.

Director Steve Elms purchased 14,000 shares across 2 separate transactions totaling $217,420.00, with a blended average price of $15.53. The purchases occur as ADMA trades near the lower end of its 52-week range ($13.99–$24.51), down 35.5% from the 52-week high and down 20.2% over the past 90 days. Elms' prior open-market trading shows 1 prior buy with a 100% 90-day win rate (+5.3% return), though his cross-ticker sell history has been less favorably timed (37.50% well-timed rate). At the same ticker, Elms' 5 prior trades (all sales) show a 3 of 5 pattern of well-timed exits, with recent June 2025 sales capturing declines. This buy adds 14,000 shares to his post-transaction total of 2,045,730 shares, a 0.7% increase in holdings. The company's fundamentals remain solid—$134.2M latest quarterly revenue, net income of $36.4M, +19.6% annual revenue growth, and a P/E of 23.60—providing a backdrop for the purchase decision at depressed prices.

Director Steve Elms sold 425,621 shares of ADMA for $8,829,333.47 across 3 days, reducing holdings 83%

Director Steve Elms executed 3 separate sales totaling 425,621 shares for $8,829,333.47 over a three-day window (June 12–16, 2025), with prices ranging from $20.24 to $21.69 and a blended average of $20.74. This sale reduced his holdings from 512,951 shares to 87,330 shares, a -83.0% reduction in his stake. The timing is notable: his prior 5 sales at ADMA (March 2024) all resulted in 90-day gains of +69.1% to +79.4%, meaning the stock rose significantly after each prior sale—a pattern of poorly-timed exits. His cross-ticker track record shows 5 prior sells with a 0.00% well-timed rate (no negative post-sale returns observed), reinforcing a pattern where subsequent price appreciation has followed his sales. The company's current fundamentals are strong (P/E of 23.45, +65.2% annual revenue growth, $26.9M net income in the latest quarter), and the stock is trading near its 52-week high at $20.40, only -16.8% below the $24.51 peak. The scale and speed of this divestment—83% of his prior position—stands in contrast to the company's solid operational performance.

Director Elms buys 11.1K shares of MRKR at $3.20; stock down 43.5% from 52-week high amid -63.3% revenue decline.

Director Steve Elms purchased 11,085 shares at $3.20 on 2024-12-23, increasing his holdings from 314,285 shares to 325,370 shares. The purchase occurred at a price significantly below the 52-week high of $5.96 and modestly below the current price of $3.37, though the stock has declined 43.5% from peak. The company faces material operational headwinds: quarterly revenue stands at $1,926,020.00 with a net loss of $2,308,192.00, and annual revenue has contracted 63.3% year-over-year. Across Elms's cross-ticker track record, his 5 prior open-market sales show a 0.00% well-timed rate and an average 90-day return of +75.0%, indicating his prior exit decisions have not captured downside protection. This open-market purchase adds a data point but must be evaluated against the company's significant operational deterioration and the director's mixed execution history on prior trades.